Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Facial Aesthetics Market, by Product
1.4.2 North America Facial Aesthetics Market, by Application
1.4.3 North America Facial Aesthetics Market, by End User
1.4.4 North America Facial Aesthetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jan – 2022, Mar) Leading Players
Chapter 4. North America Facial Aesthetics Market by Product
4.1 North America Dermal fillers Market by Country
4.2 North America Botulinum toxin Market by Country
4.3 North America Microdermabrasion Market by Country
4.4 North America Chemical peels Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Facial Aesthetics Market by Application
5.1 North America Facial line correction treatment Market by Country
5.2 North America Scar treatment Market by Country
5.3 North America Lip enhancement Market by Country
5.4 North America Restoration of volume or Fullness Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Facial Aesthetics Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Specialty & Dermatology Clinics Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Facial Aesthetics Market by Country
7.1 US Facial Aesthetics Market
7.1.1 US Facial Aesthetics Market by Product
7.1.2 US Facial Aesthetics Market by Application
7.1.3 US Facial Aesthetics Market by End User
7.2 Canada Facial Aesthetics Market
7.2.1 Canada Facial Aesthetics Market by Product
7.2.2 Canada Facial Aesthetics Market by Application
7.2.3 Canada Facial Aesthetics Market by End User
7.3 Mexico Facial Aesthetics Market
7.3.1 Mexico Facial Aesthetics Market by Product
7.3.2 Mexico Facial Aesthetics Market by Application
7.3.3 Mexico Facial Aesthetics Market by End User
7.4 Rest of North America Facial Aesthetics Market
7.4.1 Rest of North America Facial Aesthetics Market by Product
7.4.2 Rest of North America Facial Aesthetics Market by Application
7.4.3 Rest of North America Facial Aesthetics Market by End User
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Acquisition and Mergers:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.3 Galderma S.A.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Approvals and Trials:
8.3.2.3 Acquisition and Mergers:
8.4 Candela Medical Corporation (Syneron Medical Ltd.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Geographical Expansions:
8.5 Teoxane S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Approvals and Trials:
8.6 Johnson and Johnson
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Ipsen Pharma Biotech SAS
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fotona D.o.o.
8.10.1 Company Overview
Unique Offerings 